The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
Abstract
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Self-citationAn analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Reubi, J. C., Schär, J.-C., Waser, B., Wenger, S., Heppeler, A., Schmitt, J. S., & Mäcke, H. R. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050034 · Cited by 1,127
Self-citationCarcinoid TumorsAn analysis of 2837 cases
Godwin, J. D. (1975) · Cancer · doi:10.1002/1097-0142(197508)36:2<560::aid-cncr2820360235>3.0.co;2-4 · Cited by 1,106
Current Status of Gastrointestinal Carcinoids
Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., & Shapiro, M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.038 · Cited by 848
Moertel, C. G., Kvols, L. K., O'Connell, M. J., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2<227::aid-cncr2820680202>3.0.co;2-i · Cited by 840
Sarmiento, J. M., Heywood, G., Rubin, J., Ilstrup, D. M., Nagorney, D. M., & Que, F. G. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00230-8 · Cited by 773
Histological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Hepatic neuroendocrine metastases: does intervention alter outcomes?1
Chamberlain, R. S., Canes, D., Brown, K. T., Saltz, L., Jarnagin, W., Fong, Y., & Blumgart, L. H. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00222-2 · Cited by 622
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
Pellikka, P. A., Tajik, A. J., Khandheria, B. K., Seward, J. B., Callahan, J. A., Pitot, H. C., & Kvols, L. K. (1993) · Circulation · doi:10.1161/01.cir.87.4.1188 · Cited by 614
Life history of the carcinoid tumor of the small intestine
Moertel, C. G., Sauer, W. G., Dockerty, M. B., & Baggenstoss, A. H. (1961) · Cancer · doi:10.1002/1097-0142(196109/10)14:5<901::aid-cncr2820140502>3.0.co;2-q · Cited by 555
Faiss, S., Pape, U.-F., Böhmig, M., Dörffel, Y., Mansmann, U., Golder, W., Riecken, E. O., & Wiedenmann, B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.142 · Cited by 501
Self-citationTreatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
Mitry, E., Baudin, E., Ducreux, M., Sabourin, J.-C., Rufié, P., Aparicio, T., Lasser, P., Elias, D., Duvillard, P., Schlumberger, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690325 · Cited by 496
Karnofsky memorial lecture. An odyssey in the land of small tumors.
Moertel, C. G. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1502 · Cited by 473
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P., Konijnenberg, M. W., Srinivasan, A., Erion, J. L., Schmidt, M. A., Bugaj, J. L., de Jong, M., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100574 · Cited by 471
Self-citationHepatic resection for metastatic neuroendocrine carcinomas
Que, F. G., Nagorney, D. M., Batts, K. P., Linz, L. J., & Kvols, L. K. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80107-x · Cited by 462
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
Waldherr, C., Pless, M., Maëcke, H. R., Schumacher, T., Crazzolara, A., Nitzsche, E. U., Haldemann, A. R., & Mueller‐Brand, J. (2002) · PubMed · Cited by 445
Valkema, R., de Jong, M., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Lugtenburg, P. J., de Jong, F. H., Christiansen, A., Kam, B. L. R., de Herder, W. W., et al. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc/2002.31025 · Cited by 435
Self-citationCarcinoid Tumor of the Appendix: Treatment and Prognosis
Moertel, C. G., Weiland, L. H., Nagorney, D. M., & Dockerty, M. B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712313172704 · Cited by 427
Kwekkeboom, D. J., Bakker, W. H., Kam, B. L., Teunissen, J. J. M., Kooij, P. P. M., de Herder, W. W., Feelders, R. A., van Eijck, C. H. J., de Jong, M., Srinivasan, A., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1050-8 · Cited by 424
Self-citationYttrium-90 DOTATOC: first clinical results
Otte, A., Herrmann, R., Heppeler, A., Behe, M., Jermann, E., Powell, P., Maecke, H. R., & Muller, J. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050476 · Cited by 420
Waldherr, C., Pless, M., Maecke, H. R., Haldemann, A., & Mueller-Brand, J. (2001) · Annals of Oncology · doi:10.1023/a:1011160913619 · Cited by 396
Rubin, J., Ajani, J., Schirmer, W., Venook, A. P., Bukowski, R., Pommier, R., Saltz, L., Dandona, P., & Anthony, L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.600 · Cited by 389
Cytoreductive hepatic surgery for neuroendocrine tumors.
Gp, M., Nagorney, D. M., Lk, K., Cg, M., & Cs, G. (1990) · PubMed · Cited by 381
Isolated Liver Metastases from Neuroendocrine Tumors: Does Resection Prolong Survival?
Chen, H., Hardacre, J. M., Uzar, A., Cameron, J. L., & Choti, M. A. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00099-4 · Cited by 371
Orlefors, H., Sundin, A., Garske, U., Juhlin, C., Oberg, K., Skogseid, B., Langstrom, B., Bergstrom, M., & Eriksson, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1938 · Cited by 329
Self-citationRolleman, E., Valkema, R., de Jong, M., Kooij, P., & Krenning, E. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0982-3 · Cited by 321
Self-citationBodei, L., Cremonesi, M., Zoboli, S., Grana, C., Bartolomei, M., Rocca, P., Caracciolo, M., Mäcke, H. R., Chinol, M., & Paganelli, G. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1023-y · Cited by 305
Factors Associated with Progression of Carcinoid Heart Disease
Møller, J. E., Connolly, H. M., Rubin, J., Seward, J. B., Modesto, K., & Pellikka, P. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021451 · Cited by 298
Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies
Anthony, L. B., Woltering, E. A., Espenan, G. D., Cronin, M. D., Maloney, T. J., & McCarthy, K. E. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31769 · Cited by 279
LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE CARCINOMA: An Analysis of 103 Patients
Lehnert, T. (1998) · Transplantation · doi:10.1097/00007890-199811270-00007 · Cited by 268
Treatment with cisplatin and etoposide in patients with neuroendocrine tumors
Fj�llskog, M.-L. H., Granberg, D. P. K., Welin, S. L. V., Eriksson, C., �berg, K. E., Janson, E. T., & Eriksson, B. K. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1101::aid-cncr1426>3.0.co;2-v · Cited by 262
Self-citationAndrews, J. C., Walker, S., Ackermann, R. J., Cotton, L., Ensminger, W. D., & Shapiro, B. (1994) · PubMed · Cited by 261
Saltz, L., Trochanowski, B., Buckley, M., Heffernan, B., Niedzwiecki, D., Tao, Y., & Kelsen, D. (1993) · Cancer · doi:10.1002/1097-0142(19930701)72:1<244::aid-cncr2820720143>3.0.co;2-q · Cited by 260
Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases
Siperstein, A. E., Rogers, S. J., Hansen, P. D., & Gitomirsky, A. (1997) · Surgery · doi:10.1016/s0039-6060(97)90221-x · Cited by 260
Aggressive surgery for metastatic liver neuroendocrine tumors
Norton, J. A., Warren, R. S., Kelly, M. G., Zuraek, M. B., & Jensen, R. T. (2003) · Surgery · doi:10.1016/j.surg.2003.07.025 · Cited by 255
Arnold, R., Rinke, A., Klose, K.-J., Müller, H.-H., Wied, M., Zamzow, K., Schmidt, C., Schade-Brittinger, C., Barth, P., Moll, R., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00481-7 · Cited by 254
Self-citationKwekkeboom, D. J., & Krenning, E. P. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31022 · Cited by 252
Self-citation111In- and 90Y-DOTA-Lanreotide: Results and implications of the MAURITIUS trial
Virgolini, I., Britton, K., Buscombe, J., Moncayo, R., Paganelli, G., & Riva, P. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31565 · Cited by 243
Carcinoid tumour of the appendix
Goede, A. C., Caplin, M. E., & Winslet, M. C. (2003) · British Journal of Surgery · doi:10.1002/bjs.4375 · Cited by 238
Self-citationLaparoscopic Radiofrequency Ablation of Neuroendocrine Liver Metastases
Berber, E., Flesher, N., & Siperstein, A. E. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6629-5 · Cited by 236
Hepatic surgery for metastases from neuroendocrine tumors
Sarmiento, J. M., & Que, F. G. (2003) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00076-5 · Cited by 227
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
Aparicio, T., Ducreux, M., Baudin, E., Sabourin, J.-C., De Baere, T., Mitry, E., Schlumberger, M., & Rougier, P. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00073-9 · Cited by 226
Wymenga, A. N. M., Eriksson, B., Salmela, P. I., Jacobsen, M. B., Van Cutsem, E. J. D. G., Fiasse, R. H., Välimäki, M. J., Renstrup, J., de Vries, E. G. E., & Öberg, K. E. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1111 · Cited by 226
Self-citationLocal Recurrence After Laparoscopic Radiofrequency Thermal Ablation of Hepatic Tumors
Siperstein, A., Garland, A., Engle, K., Rogers, S., Berber, E., Foroutani, A., String, A., Ryan, T., & Ituarte, P. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0106-x · Cited by 223
Kölby, L., Persson, G., Franzén, S., & Ahrén, B. (2003) · British Journal of Surgery · doi:10.1002/bjs.4149 · Cited by 222
PGP 9.5, a new marker for human neuroendocrine tumours
RODE, J., DHILLON, A. P., DORAN, J. F., JACKSON, P., & THOMPSON, R. J. (1985) · Histopathology · doi:10.1111/j.1365-2559.1985.tb02431.x · Cited by 221
[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy
de Jong, M., Breeman, W. A. P., Bernard, B. F., Bakker, W. H., Schaar, M., van Gameren, A., Bugaj, J. E., Erion, J. L., Schmidt, M. A., Srinivasan, A., et al. (2001) · International Journal of Cancer · Cited by 210
Self-citationde Jong, M., Breeman, W. A., Bakker, W., Kooij, P. P. M., Bernard, B. F., Hofland, L. J., Visser, T. J., Srinivasan, A., Schmidt, M. A., Erion, J. L., et al. (1998) · PubMed · Cited by 209
Self-citationReceptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide
Paganelli, G., Zoboli, S., Cremonesi, M., Bodei, L., Ferrari, M., Grana, C., Bartolomei, M., Orsi, F., De Cicco, C., Mäcke, H. R., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100490 · Cited by 206
Ruszniewski, P., Ducreux, M., Chayvialle, J. A., Blumberg, J., Cloarec, D., Michel, H., Raymond, J. M., Dupas, J. L., Gouerou, H., Jian, R., et al. (1996) · Gut · doi:10.1136/gut.39.2.279 · Cited by 206
Self-citationRecent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
Kaltsas, G., Rockall, A., Papadogias, D., Reznek, R., & Grossman, A. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510015 · Cited by 206
The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors
Ducreux, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02003-7 · Cited by 196
Frank, M. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00146-x · Cited by 191
Eriksson, B., Renstrup, J., Imam, H., & Öberg, K. (1997) · Annals of Oncology · doi:10.1023/a:1008205415035 · Cited by 190
Self-citationRosenau, J., Bahr, M. J., von Wasielewski, R., Mengel, M., Schmidt, H. H. J., Nashan, B., Lang, H., Klempnauer, J., Manns, M. P., & Boeker, K. H. W. (2002) · Transplantation · doi:10.1097/00007890-200202150-00012 · Cited by 188
Interferon in the Management of Neuroendocrine GEP-Tumors
Öberg, K. (2000) · Digestion · doi:10.1159/000051862 · Cited by 187
Self-citationTranscatheter chemoembolization of progressive carcinoid liver metastasis.
Therasse, E., Breittmayer, F., Roche, A., De Baere, T., Indushekar, S., Ducreux, M., Lasser, P., Elias, D., & Rougier, P. (1993) · Radiology · doi:10.1148/radiology.189.2.7692465 · Cited by 172
Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis.
Gb, T., van Heerden, J. A., Jk, M., Schutt, A. J., Dm, I., & Carney, J. A. (1985) · PubMed · Cited by 171
Hepatic Arterial Chemoembolization for Metastatic Neuroendocrine Tumors
Clouse, M. E., Perry, L., Stuart, K., & Stokes, K. R. (1994) · Digestion · doi:10.1159/000201208 · Cited by 167
Koura, A. N., Giacco, G. G., Curley, S. A., Skibber, J. M., Feig, B. W., & Ellis, L. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970401)79:7<1294::aid-cncr4>3.0.co;2-h · Cited by 167
Chemotherapy and biotherapy in the treatment of neuroendocrine tumours
Öberg, K. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s111 · Cited by 167
Self-citationMoertel, C. G., Rubin, J., & Kvols, L. K. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.7.865 · Cited by 165
Surgical treatment of mid‐gut carcinoid tumors
Makridis, C., Öberg, K., Juhlin, C., Rastad, J., Johansson, H., Lörelius, L. E., & Åkerström, G. (1990) · World Journal of Surgery · doi:10.1007/bf01658532 · Cited by 161
Self-citationSumming up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook
Eriksson, B., & Öberg, K. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s31 · Cited by 160
Self-citationRadiofrequency Tissue Ablation Using Cooled Tip for Liver Metastases of Endocrine Tumors
Hellman, P., Ladjevardi, S., Skogseid, B., Åkerström, G., & Elvin, A. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6663-3 · Cited by 159
Kress, O., Wagner, H., Wied, M., Klose, K.-J., Arnold, R., & Alfke, H. (2003) · Digestion · doi:10.1159/000074522 · Cited by 150
Self-citationRadiofrequency ablation of neuroendocrine liver metastases—the Middlesex experience
Gillams, A. R., Cassoni, A. M., Conway, G. S., & Lees, W. R. (2005) · Abdominal Imaging · doi:10.1007/s00261-004-0258-4 · Cited by 145
Prognostic variables in patients with gastrointestinal carcinoid tumours
McDermott, E. W. M., Gudurić, B., & Brennan, M. F. (1994) · British journal of surgery · doi:10.1002/bjs.1800810725 · Cited by 142
Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Perry, L. J., Stuart, K. E., Stokes, K. R., & Clouse, M. E. (1994) · PubMed · Cited by 135
Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours
Janson, E. T., Ahlström, H. K., Andersson, T., & Öberg, K. E. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90060-f · Cited by 130
Self-citationChinol, M., Bodei, L., Cremonesi, M., & Paganelli, G. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31563 · Cited by 127
Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR
Tomassetti, Migliori, Corinaldesi, & Gullo (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00738.x · Cited by 125
Surgical Management of Left-Sided Carcinoid Heart Disease
Connolly, H. M., Schaff, H. V., Mullany, C. J., Rubin, J., Abel, M., & Pellikka, P. A. (2001) · Circulation · doi:10.1161/hc37t1.094898 · Cited by 125
Carcinoid tumors of the gastrointestinal tract: evaluation with endoscopic ultrasonography
Yoshikane, H., Tsukamoto, Y., Niwa, Y., Goto, H., Hase, S., Mizutani, K., & Nakamura, T. (1993) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(93)70109-1 · Cited by 121
Diaco, D. S., Hajarizadeh, H., Mueller, C. R., Fletcher, W. S., Pommier, R. F., & Woltering, E. A. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80210-4 · Cited by 115
Survival of Patients with Disseminated Midgut Carcinoid Tumors after Aggressive Tumor Reduction
Wängberg, B., Westberg, G., Tylén, U., et al. (1996) · World Journal of Surgery · doi:10.1007/s002689900136 · Cited by 114
A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors
Ansell, S. M., Pitot, H. C., Burch, P. A., Kvols, L. K., Mahoney, M. R., & Rubin, J. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8<1543::aid-cncr1163>3.0.co;2-n · Cited by 107
Meijer, W. G., van der Veer, E., Jager, P. L., van der Jagt, E. J., Piers, B. A., Kema, I. P., de Vries, E. G. E., & Willemse, P. H. B. (2003) · PubMed · Cited by 106
Ardill, J. E. S., & Erikkson, B. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100459 · Cited by 103
de Jong, M., Breeman, W. A. P., Bernard, B. F., Bakker, W. H., Visser, T. J., Kooij, P. P. M., van Gameren, A., & Krenning, E. P. (2001) · PubMed · Cited by 102
Self-citationSlow-Release Lanreotide Treatment in Endocrine Gastrointestinal Tumors
Tomassetti, P., Migliori, M., & Gullo, L. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.465_q.x · Cited by 101
State of the art and perspectives
King, M. (1993) · Machine Translation · doi:10.1007/bf00398472 · Cited by 98
Experience with Indium-111 and Yttrium-90-Labeled Somatostatin Analogs
Virgolini, I. J., Traub‐Weidinger, T., Novotny, C., Leimer, M., Fueger, B. J., Li, S., Patri, P., Pangerl, T., Angelberger, P., Raderer, M., et al. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023393756 · Cited by 97
Indications and Results of Liver Transplantation in Patients with Neuroendocrine Tumors
Olausson, M., Friman, S., Cahlin, C., Nilsson, O., Jansson, S. K. G., Wängberg, B., & Ahlman, H. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6631-y · Cited by 93
Self-citationBorch, K., Stridsberg, M., Burman, P., & Rehfeld, J. F. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709000194 · Cited by 91
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid
Bukowski, R. M., Tangen, C. M., Peterson, R. F., Fleming, T. R., Taylor, S. A., Rinehart, J. J., Eyre, H. J., Rivkin, S. E., Macdonald, J. S., & A Southwest Oncology Group Study (1994) · Cancer · Cited by 90
Ricci, S., Antonuzzo, A., Galli, L., Ferdeghini, M., Bodei, L., Orlandini, C., & Conte, P. (2000) · Annals of Oncology · doi:10.1023/a:1008383132024 · Cited by 90
Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome.
Fjälling, M., Andersson, P., Forssell-Aronsson, E. B., Grétarsdóttir, J., Johansson, V., Tisell, L. E., Wängberg, B., Nilsson, O., Berg, G., Michanek, A., et al. (1996) · PubMed · Cited by 87
Self-citationDOTA-Lanreotide: A Novel Somatostatin Analog for Tumor Diagnosis and Therapy1
Smith-Jones, P. M., Bischof, C., Leimer, M., et al. (1999) · Endocrinology · doi:10.1210/endo.140.11.7126 · Cited by 85
Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
de Jong, M., Breeman, W. A. P., Bernard, H. F., Kooij, P. P. M., Slooter, G. D., van Eijck, C. H. J., Kwekkeboom, D. J., Valkema, R., Mäcke, H. R., & Krenning, E. P. (1999) · PubMed · Cited by 71
Self-citationJacobsen, M. B., Hanssen, L. E., Kolmannskog, F., Schrumpf, E., Vatn, M. H., & Bergan, A. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509096329 · Cited by 71
Norton, J. A. (2009) · Digestion · doi:10.1159/000201209 · Cited by 69
Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?
Välimäki, M. J., Järvinen, H., Salmela, P. I., Sane, T., Sjöblom, S. M., & Pelkonen, R. (1991) · Cancer · doi:10.1002/1097-0142(19910201)67:3<547::aid-cncr2820670302>3.0.co;2-j · Cited by 68
Chaudhry, A., berg, K. O., & Wilander, E. (1992) · Tumor Biology · doi:10.1159/000217749 · Cited by 68
Self-citationInterventional Treatment of Gastrointestinal Neuroendocrine Tumours
Ahlman, H. K., Wängberg, B., Jansson, S., Friman, S., Olausson, M., Tylén, U., & Nilsson, O. (2000) · Digestion · doi:10.1159/000051857 · Cited by 67
Self-citationThe Use of Chemotherapy in the Management of Neuroendocrine Tumors
Öberg, K. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30142-7 · Cited by 67
Self-citationLiver Transplantation for Treatment of Metastatic Neuroendocrine Tumors
Ahlman, H., Friman, S., Cahlin, C., Nilsson, O., Jansson, S. K. G., Wängberg, B., & Olausson, M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.029 · Cited by 65
Self-citationLeong, W. L., & Pasieka, J. L. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10062 · Cited by 63
Luzio, S. D., & Rigolin, V. H. (2000) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-000-0035-9 · Cited by 54
Surgical Treatment of Carcinoid Tumors of the Small Bowel, Appendix, Colon and Rectum
Rothmund, M., & Kisker, O. (2009) · Digestion · doi:10.1159/000201207 · Cited by 53
Abdominal Surgery in Patients with Midgut Carcinoid Tumors
Åkerström, G., Makridis, C., & Johansson, H. (1991) · Acta Oncologica · doi:10.3109/02841869109092416 · Cited by 48
Cardiac manifestations in mid-gut carcinoid disease
Jacobsen, M. B., NITTER‐HAUGE, S., Bryde, P., & Hanssen, L. E. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060894 · Cited by 44
Current concepts in diagnosis and management
Strauss, J. (1981) · Plenum eBooks · Cited by 39
Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors
Pelley, R. J., & Bukowski, R. M. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199901000-00008 · Cited by 37
Carcinoid Heart Disease: an Update
Quaedvlieg, P., Lamers, C. B. H. W., & Taal, B. G. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320621481 · Cited by 19
Surgery for carcinoid tumours of the lower gastrointestinal tract
Goede, A., & Winslet, M. C. (2003) · Colorectal Disease · doi:10.1046/j.1463-1318.2003.00457.x · Cited by 19
Self-citation[Yttrium 90 DOTATOC: a new somatostatin analog for cancer therapy of neuroendocrine tumors].
Otte, A., Herrmann, R. P., Mäcke, H. R., & Müller‐Brand, J. (1999) · PubMed · Cited by 16
Wajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4
Cited by
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Self-citationTNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Self-citationRindi, G., Klöppel, G., Couvelard, A., Komminoth, P., Körner, M., Lopes, J. M., McNicol, A.-M., Nilsson, O., Perren, A., Scarpa, A., et al. (2007) · Virchows Archiv · doi:10.1007/s00428-007-0452-1 · Cited by 955
Self-citationGastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Metz, D. C., & Jensen, R. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.047 · Cited by 816
NANETS Treatment Guidelines: Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Kulke, M. H., Anthony, L. B., Bushnell, D. L., de Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., et al. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb168 · Cited by 574
Self-citation
Metadata
- Authors
- Plöckinger, U., Rindi, G., Arnold, R., Eriksson, B., Krenning, E. P., de Herder, W. W., Goede, A., Caplin, M., Öberg, K., Reubi, J. C., Nilsson, O., Delle Fave, G., Ruszniewski, P., Ahlman, H., & Wiedenmann, B.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 80
- Issue
- 6
- Pages
- 394-424
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2031250625
- Cited by
- 477
- References
- 110
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.